Several studies have used MRM to obtain detailed expression profiles of sEV proteins and to identify potential biomarkers such as HSP90 and syndecan-1 in bladder cancer, and annexin A2 and clusterin in Alzheimer's disease [139–141]. The gene discussed is CLU; the disease is early-onset autosomal dominant Alzheimer disease.